India tightens norms for pharma M&A
10 November 2011
On 8 November 2011, the Indian government amended its foreign investment rules imposing a requirement to seek its approval for foreign direct investment ("FDI") in existing Indian pharmaceutical companies. FDI in greenfield pharmaceutical ventures can be made without the requirement of any such approval.
Download PDF